Centrus Energy stock thesis draws investor interest, JPMorgan notes

Published 14/07/2025, 14:14
Centrus Energy stock thesis draws investor interest, JPMorgan notes

Investing.com - JPMorgan has shared feedback from investors following its recent initiation of coverage on Centrus Energy (NYSE:LEU), a supplier of enriched uranium. The company’s stock has seen remarkable performance, surging over 323% in the past year and currently trading near $206, just shy of its 52-week high of $211.31.

The investment bank noted that investors "generally agreed" with its high risk/high reward thesis on Centrus Energy, though questions arose about the sustainability of the company’s current valuation.

According to JPMorgan, investor discussions centered on four key areas: Department of Energy funding scenarios, outlook for the broker-trader business, competitive landscape among Western players, and the stock’s recent outperformance.

The bank reported that investors highlighted challenges in evaluating the stock at current levels due to "wide variety of outcomes around capex, funding, timing, production economics, and geopolitical uncertainty."

JPMorgan acknowledged these concerns, stating the current price "prices in a high level of financial and operational success with few granular guideposts as to what the business could look like on a longer-term basis."

In other recent news, Centrus Energy Corp. reported the successful delivery of 900 kilograms of High-Assay, Low-Enriched Uranium (HALEU) to the U.S. Department of Energy, meeting the Phase II contract target. This milestone allows Centrus to advance to Phase III, with a contract extension securing production through June 2026. Stifel reiterated a Buy rating on Centrus Energy, highlighting its strategic role in the U.S. nuclear supply chain and setting a price target of $220 based on long-term discounted cash flow analysis. William Blair also maintained an Outperform rating, noting Centrus’s transition to a domestic uranium enricher and its potential as a key player in the nuclear revival. JPMorgan initiated coverage with a neutral rating and a $148 price target, citing Centrus’s position in the nuclear value chain and its need for government funding to support enrichment efforts. The firm acknowledged Centrus’s growing backlog and improved balance sheet as factors for potential future growth. These developments underscore Centrus Energy’s pivotal role in the nuclear sector and its ongoing efforts to expand enrichment capabilities.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.